Thermo Fisher Scientific Long Term Debt 2010-2022 | TMO

Thermo Fisher Scientific long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • Thermo Fisher Scientific long term debt for the quarter ending December 31, 2022 was $28.909B, a 10.59% decline year-over-year.
  • Thermo Fisher Scientific long term debt for 2022 was $28.909B, a 10.59% decline from 2021.
  • Thermo Fisher Scientific long term debt for 2021 was $32.333B, a 69.22% increase from 2020.
  • Thermo Fisher Scientific long term debt for 2020 was $19.107B, a 11.89% increase from 2019.
Thermo Fisher Scientific Annual Long Term Debt
(Millions of US $)
2022 $28,909
2021 $32,333
2020 $19,107
2019 $17,076
2018 $17,719
2017 $18,873
2016 $15,372
2015 $11,420
2014 $12,352
2013 $9,500
2012 $7,031
2011 $5,755
2010 $2,031
2009 $2,066
Thermo Fisher Scientific Quarterly Long Term Debt
(Millions of US $)
2022-12-31 $28,909
2022-09-30 $28,150
2022-06-30 $29,250
2022-03-31 $31,389
2021-12-31 $32,333
2021-09-30 $21,688
2021-06-30 $18,773
2021-03-31 $18,641
2020-12-31 $19,107
2020-09-30 $21,091
2020-06-30 $20,638
2020-03-31 $19,231
2019-12-31 $17,076
2019-09-30 $16,392
2019-06-30 $16,663
2019-03-31 $16,812
2018-12-31 $17,719
2018-09-30 $17,760
2018-06-30 $17,709
2018-03-31 $18,122
2017-12-31 $18,873
2017-09-30 $21,118
2017-06-30 $15,256
2017-03-31 $15,188
2016-12-31 $15,372
2016-09-30 $16,940
2016-06-30 $11,632
2016-03-31 $11,653
2015-12-31 $11,420
2015-09-30 $10,278
2015-06-30 $10,664
2015-03-31 $10,696
2014-12-31 $12,352
2014-09-30 $11,389
2014-06-30 $12,502
2014-03-31 $15,197
2013-12-31 $9,500
2013-09-30 $6,718
2013-06-30 $6,721
2013-03-31 $6,724
2012-12-31 $7,031
2012-09-30 $7,038
2012-06-30 $5,746
2012-03-31 $5,751
2011-12-31 $5,755
2011-09-30 $6,115
2011-06-30 $4,009
2011-03-31 $1,801
2010-12-31 $2,031
2010-09-30 $2,061
2010-06-30 $2,033
2010-03-31 $1,930
2009-12-31 $2,066
2009-09-30 $1,965
2009-06-30 $2,028
2009-03-31 $2,025
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $216.492B $44.915B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $49.046B 32.63
Alcon (ALC) Switzerland $33.478B 30.63
STERIS (STE) Ireland $18.499B 23.44
Fresenius Medical Care AG KGaA (FMS) Germany $12.188B 12.74
Teleflex (TFX) United States $11.596B 18.91
Penumbra (PEN) United States $10.582B 1630.35
Globus Medical (GMED) United States $5.353B 25.78
Integer Holdings (ITGR) United States $2.578B 19.99
Glaukos (GKOS) United States $2.434B 0.00
Paragon 28 (FNA) United States $1.402B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.348B 17.53
Nevro (NVRO) United States $1.175B 0.00
Artivion (AORT) United States $0.496B 244.80